Wednesday, January 21, 2026 | 01:01 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 56 - Pharma

Take Solutions establishes life sciences firm Navitas

The new company, a spinoff of Take Solutions' life sciences business, will focus on the life sciences domain to compete with industry leaders

Take Solutions establishes life sciences firm Navitas
Updated On : 23 Jan 2015 | 4:51 PM IST

Belgium's Eubage Laboratory plans to invest $17 mn in Dr Datsons Labs

European firm proposes to invest in Dr Datsons' manufacturing facilities and manufacture & co-market 20 nutraceutical products in India

Belgium's Eubage Laboratory plans to invest $17 mn in Dr Datsons Labs
Updated On : 21 Jan 2015 | 2:49 PM IST

Biogen Idec to acquire Convergence Pharma for $200 mn

Convergence shareholders will eligible to receive additional payments up to $475 million contingent on future milestones

Image
Updated On : 20 Jan 2015 | 5:13 PM IST

Roche acquires French biotech firm Trophos

Trophos will receive an upfront payment of Euro 120 mn, and additional payments of up to Euro 350 mn based on achievement of certain predetermined milestones

Roche acquires French biotech firm Trophos
Updated On : 20 Jan 2015 | 5:10 PM IST

Suven Life secures four patents in Australia, Hong Kong & Japan

Patents, which are valid through 2030, have been granted for the new chemical entity, which can be used for the treatment of disorders associated with neurodegenerative diseases

Image
Updated On : 20 Jan 2015 | 4:45 PM IST

Strides Arcolab inks licensing pact for Gilead's HIV drug

As per the pact, Strides Arcolab will manufacture and distribute tenofovir alafenamide (TAF) based HIV treatments in 112 developing countries

Strides Arcolab inks licensing pact for Gilead's HIV drug
Updated On : 20 Jan 2015 | 4:39 PM IST

Air Liquide acquires Germany's Optimal Medical Therapies

Acquisition to strengthen Air Liquide's home healthcare offering and enabling the company to consolidate its position in the German infusion therapy market

Image
Updated On : 20 Jan 2015 | 4:35 PM IST

Make in India campaign will boost production of bio-based industries: Vikram Prabhu

In this interview, Vikram Prabhu of DuPont Industrial Biosciences, discusses the market potential of bio-based ingredients and role India can play in the global industrial biotechnology arena

Make in India campaign will boost production of bio-based industries: Vikram Prabhu
Updated On : 19 Jan 2015 | 6:58 PM IST

Piramal Enterprises plans to buy US-based Coldstream Laboratories

Ajay Piramal-promoted healthcare major is holding talks with University of Kentucky to acquire Coldstream, which operates a USFDA-approved facility, for $ 30.65 million (about Rs 188 cr)

Piramal Enterprises plans to buy US-based Coldstream Laboratories
Updated On : 19 Jan 2015 | 4:30 PM IST

Atul Ltd receives USFDA's approval for Dapsone facility

Dapsone, also known as diaminodiphenyl sulfone, is an antibiotic commonly used in combination with rifampicin and clofazimine for the treatment of leprosy

Atul Ltd receives USFDA's approval for Dapsone facility
Updated On : 17 Jan 2015 | 1:38 PM IST

GSK Consumer buys Novartis India's OTC business for Rs 109 cr

Transaction was a result of a deal, signed last year, as per which Novartis and GlaxoSmithKline agreed to merge their global consumer healthcare businesses

Image
Updated On : 15 Jan 2015 | 5:22 PM IST

Natco Pharma settles patent dispute with US firm BMS

The patent dispute, which was settled in IPAB, was over the patent of Hepatitis B drug entecavir, owned by Bristol-Myers Squibb (BMS)

Image
Updated On : 13 Jan 2015 | 11:54 PM IST

US-based LA Care Health selects Infosys to implement IT project

This IT solution will help improve access to health benefits for 24,000 members on its LA Care Covered plan offered through the Covered California health insurance marketplace

Image
Updated On : 13 Jan 2015 | 11:36 PM IST

Court orders Cipla to stop sale of generic of Novartis' respiratory drug

Novartis had moved the Delhi High Court in December last year, seeking to restrain Cipla from selling the generic version of Onbrez

Court orders Cipla to stop sale of generic of Novartis' respiratory drug
Updated On : 13 Jan 2015 | 11:33 PM IST

Celestial Biolabs to launch patented anti-diabetic product

The company plans to launch this natural sea based vegetarian product tentatively by April 2015

Image
Updated On : 13 Jan 2015 | 11:30 PM IST

Shire Plc to acquire NPS Pharma for $5.2 bn

The company will accelerate the growth of NPS Pharma's innovative portfolio through its market expertise in gastrointestinal disorders, core capabilities in rare disease patient management, etc

Shire Plc to acquire NPS Pharma for $5.2 bn
Updated On : 12 Jan 2015 | 6:04 PM IST

AMRI buys Aptuit's two facilities in US & UK for $60 mn

Significantly expands AMRI's analytical services capabilities and extends drug development services to include sterile injectable formulation development

AMRI buys Aptuit's two facilities in US & UK for $60 mn
Updated On : 12 Jan 2015 | 6:01 PM IST

Jubilant Pharma appoints GP Singh as CEO

Prior to Jubilant, Singh had served as president of Sun Pharmaceuticals, USA

Image
Updated On : 06 Jan 2015 | 4:32 PM IST

Lupin launches hypertension drug in US

The company's valsartan tablet is the AB rated generic equivalent of Novartis' Diovan tablet, which had annual US sales of $2.08 bn

Image
Updated On : 06 Jan 2015 | 3:57 PM IST

Suven Life receives patents in Eurasia, Japan and Mexico

The company was granted product patents for its new chemical entities, which are used to treat disorders associated with neurodegenerative diseases

Suven Life receives patents in Eurasia, Japan and Mexico
Updated On : 06 Jan 2015 | 3:21 PM IST